4.8 Article

Microbial carbohydrate depolymerization by antigen-presenting cells: Dearnination prior to presentation by the MHCII pathway

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0800974105

关键词

antigen processing; MHC class II; reactive nitrogen species

资金

  1. NIAID NIH HHS [R01 AI039576] Funding Source: Medline

向作者/读者索取更多资源

After uptake by the endosome of an antigen-presenting cell (APC), exogenous proteins are known to be degraded into peptides by protease digestion. Here, we report the mechanism by which pure carbohydrates can be depolymerized within APC endosomes/lysosomes by nitric oxide (NO)-derived reactive nitrogen species (RNSs) and/or superoxide-derived reactive oxygen species (ROSs). Earlier studies showed that depolymerization of polysaccharide A (PSA) from Bacteroides fragilis in the endosome depends on the APC's having an intact inducible nitric oxide synthase (iNOS) gene; the chemical mechanism underlying depolymerization of a carbohydrate within the endosome/lysosome is described here. Examining the ability of the major RNSs to degrade PSA, we determined that deamination is the predominant mechanism for PSA processing in APCs and is a required step in PSA presentation to CD4(+) T cells by MHCII molecules. Structural characterization of the NO-derived product PSA-NO indicates that partial deaminative depolymerization does not alter the zwitterionic nature of PSA. Unlike native PSA, PSA-NO is presented by iNOS-deficient APCs to induce CD4+ T cell proliferation. Furthermore, metabolically active APCs are required for PSA-NO presentation. In contrast to PSA degradation by RNSs, clextran depolymerization in the endosome depends on ROSs, including hydrogen peroxide- and superoxide-derived ROSs. This study provides evidence that MHCII pathway-mediated carbohydrate antigen processing in APCs is achieved by chemical reactions. RNSs and ROSs may be involved in the presentation of glycopeptides by MHC molecules via the processing of other carbohydrate-containing antigens, such as bacterial or viral glycoproteins or glycoconjugate vaccines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Glycosyltransferases within the psrP Locus Facilitate Pneumococcal Virulence

Dustin R. Middleton, Javid Aceil, Seema Mustafa, Amy Paschall, Fikri Y. Avci

Summary: The pneumococcal serine-rich repeat protein (PsrP) is a glycosylated adhesin that plays a crucial role in the attachment of Streptococcus pneumoniae to host cells. This study characterized the glycosyltransferases responsible for PsrP glycosylation in S. pneumoniae and found that at least four glycosyltransferases are essential for biofilm formation, cell adherence, and lung infection establishment. The findings suggest that glycosylated PsrP could be a potential candidate for the design of serotype-independent pneumococcal vaccines.

JOURNAL OF BACTERIOLOGY (2021)

Article Immunology

Broadly Reactive Human Monoclonal Antibodies Targeting the Pneumococcal Histidine Triad Protein Protect against Fatal Pneumococcal Infection

Jiachen Huang, Aaron D. Gingerich, Fredejah Royer, Amy Paschall, Alma Pena-Briseno, Fikri Y. Avci, Jarrod J. Mousa

Summary: Despite the widespread use of vaccines, Streptococcus pneumoniae remains a leading cause of bacterial pneumonia. Vaccines are effective against most serotypes, but rise in nonvaccine serotypes and moderate efficacy against some vaccine serotypes contribute to high disease incidence. Human monoclonal antibodies targeting conserved pneumococcal proteins show potential for disease prevention and treatment, with opsonophagocytic activity suggesting a mechanism of protection.

INFECTION AND IMMUNITY (2021)

Article Microbiology

A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies

Ahmet Ozdilek, Jiachen Huang, Rachelle Babb, Amy Paschall, Dustin R. Middleton, Jeremy A. Duke, Liise-Anne Pirofski, Jarrod J. Mousa, Fikri Y. Avci

Summary: Capsular polysaccharides (CPSs) are major virulence factors on the surfaces of many human bacterial pathogens. The predominant use of antibodies expressing VH3 gene family in interactions with CPSs has been observed in humans and mice, with critical amino acids in carbohydrate binding identified through mutational analysis. This study provides insights into the structural requirements for interactions between CPSs and antibodies, with implications for knowledge-based vaccine design.
Article Biochemistry & Molecular Biology

Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design

Jeremy A. Duke, Amy Paschall, John Glushka, Andrew Lees, Kelley W. Moremen, Fikri Y. Avci

Summary: This study explores the use of galactose oxidase (GOase) in a chemoenzymatic approach to generate a conjugate vaccine against Streptococcus pneumoniae. The results show that GOase can generate aldehyde motifs on the capsular polysaccharides of S. pneumoniae in a site-specific and reversible manner. The conjugate vaccine synthesized using GOase demonstrates improved humoral response and functional protection compared to the traditional sodium periodate oxidation method.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Immunology

Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice

Amy Paschall, Ahmet Ozdilek, Sydney L. Briner, Melinda A. Brindley, Fikri Y. Avci

Summary: The COVID-19 pandemic emphasized the need for improved vaccination strategies and therapeutic responses. This study found that immunosuppressive drugs used in autoimmune disorders can impact immune responses to SARS-CoV-2 spike protein vaccination, and temporarily suspending certain immunosuppressants may enhance antibody responses.

VACCINE (2022)

Article Chemistry, Medicinal

Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine

Jeremy A. Duke, Amy Paschall, Lloyd S. Robinson, Cory J. Knoot, Evgeny Vinogradov, Nichollas E. Scott, Mario F. Feldman, Fikri Y. Avci, Christian M. Harding

Summary: This study presents a novel bioconjugation platform for producing a prototype multivalent GBS conjugate vaccine that shows promise in eliciting functional antibodies against GBS capsule. This proof-of-concept research marks the first step towards developing a next-generation multivalent GBS bioconjugate vaccine.

ACS INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Glycosylation as a key parameter in the design of nucleic acid vaccines

Ahmet Ozdilek, Fikri Y. Avci

Summary: It is crucial to generate vaccine antigens that are immunologically similar to native antigens. This review explores the potential impact of host protein glycosylation on the immune responses generated by nucleic acid vaccines against bacterial and viral pathogens.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2022)

Article Immunology

Immunogenicity and protective efficacy of a prototype pneumococcal bioconjugate vaccine

Javid Aceil, Amy Paschall, Cory J. Knoot, Lloyd S. Robinson, Nichollas E. Scott, Mario F. Feldman, Christian M. Harding, Fikri Y. Avci

Summary: Capsular polysaccharides are widely used as the main components of glycoconjugate vaccines against bacterial diseases. Pneumococcal conjugate vaccines are administered globally to prevent pneumococcal disease. Our previous research has shown the efficacy of a bioconjugation method in producing pneumococcal conjugate vaccines.

VACCINE (2022)

Article Microbiology

Prevalence and Homology of the Pneumococcal Serine-Rich Repeat Protein at the Global Scale

Javid Aceil, Aarya Venkat, Eric Pan, Natarajan Kannan, Fikri Y. Avci

Summary: Despite the use of multivalent conjugate vaccines, pneumococcal pneumonia is still a high-priority disease according to WHO. A protein-based, serotype-independent vaccine targeting the pneumococcal serine-rich repeat protein (PsrP) has the potential to provide comprehensive coverage. A study using genomes of clinically isolated pneumococci from the Global Pneumococcal Sequencing project revealed that PsrP is present in at least 50% of all isolates, indicating its strong vaccine potential, especially in non-vaccine serotypes.

MICROBIOLOGY SPECTRUM (2023)

Review Immunology

Emerging vaccine strategies against the incessant pneumococcal disease

Jeremy A. Duke, Fikri Y. Avci

Summary: The incidence of invasive pneumococcal disease (IPD) caused by infection with Streptococcus pneumoniae has been decreasing due to vaccination programs. However, the global burden of S. pneumoniae is still significant, emphasizing the need for new vaccination strategies. This review focuses on immune mechanisms triggered by existing pneumococcal vaccines and discusses challenges faced in selecting serotypes and using pneumococcal-derived proteins as vaccine antigens.

NPJ VACCINES (2023)

Review Microbiology

Serine-rich repeat proteins: well-known yet little-understood bacterial adhesins

Mukaddes S. Cinar, Afaq Niyas, Fikri Y. Avci

Summary: Serine-rich-repeat proteins (SRRPs) play important functional roles in bacterial-host interactions and can cause diseases. They have shared domains, including serine-rich repeat regions, and function through glycosylation reactions. Studies have shown the significance of SRRPs and their glycans in host-microbe communications.

JOURNAL OF BACTERIOLOGY (2023)

Review Biochemistry & Molecular Biology

Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease

Berna Tumoglu, Aidan Keelaghan, Fikri Y. Avci

Summary: Protein-carbohydrate interactions are crucial in maintaining immune homeostasis and regulating immune processes. This review focuses on the immune interactions of macrophage galactose-type lectin (MGL) and Tn carbohydrate antigen, highlighting their role in regulating effector T cells, immune suppression, and pathogen recognition.

GLYCOBIOLOGY (2023)

Meeting Abstract Immunology

Broadly reactive human antibodies prevent and treat pneumococcal infection

Jarrod J. Mousa, Jiachen Huang, Aaron D. Gingerich, Fredejah Royer, Amy V. Paschall, Fikri Y. Avci

JOURNAL OF IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Characterization of the β-glucuronidase Pn3Pase as the founding member of glycoside hydrolase family GH169

Paeton L. Wantuch, Satya Jella, Jeremy A. Duke, Jarrod J. Mousa, Bernard Henrissat, John Glushka, Fikri Y. Avci

Summary: Paenibacillus sp. 32352 produces an enzyme, Pn3Pase, capable of degrading the capsular polysaccharide of Streptococcus pneumoniae serotype 3. Recent studies have shown the potential of Pn3Pase as a protection against highly virulent S. pneumoniae serotype 3 infections. Biochemical analysis and mutagenesis studies have revealed that Pn3Pase establishes a new CAZy GH family and identified catalytic residues and essential domains for function. This study contributes to understanding the mechanistic and structural aspects of Pn3Pase, establishing it as a potential therapeutic approach against type 3 S. pneumoniae infections.

GLYCOBIOLOGY (2021)

Article Chemistry, Multidisciplinary

FAP-Targeted Photodynamic Therapy Mediated by Ferritin Nanoparticles Elicits an Immune Response against Cancer Cells and Cancer Associated Fibroblasts

Shiyi Zhou, Zipeng Zhen, Amy V. Paschall, Lijun Xue, Xueyuan Yang, Anne-Gaelle Bebin Blackwell, Zhengwei Cao, Weizhong Zhang, Mengzhe Wang, Yong Teng, Gang Zhou, Zibo Li, Fikri Y. Avci, Wei Tang, Jin Xie

Summary: This study developed a photodynamic therapy approach using nanoparticles specifically targeting FAP, which efficiently eradicated CAFs in tumors and induced anti-cancer immunity in murine models. Interestingly, the treatment not only elicited cellular immunity against cancer cells, but also stimulated an anti-CAFs immunity, as supported by adoptive cell transfer study.

ADVANCED FUNCTIONAL MATERIALS (2021)

暂无数据